RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2
US Application 63/335,824
Filed on 2022-04-28
Filed on 2022-04-28
UNC13A Disease Polymorphisms Lead To Increased Cryptic Exon Expression In Settings Of TDP-43 Deficiency
United Kingdom
2019418.9
Filed on 2020-12-09
2019418.9
Filed on 2020-12-09
ADAPTABLE DUAL-TUNED ON-COIL RF POWER AMPLIFIER BY AUTOMATED TUNING OF FET DRIVER CIRCUIT
US Application 63/185,219
Filed on 2021-05-06
Filed on 2021-05-06
D3 Dopamine Receptor-Selective Negative Allosteric Modulators.
US Application 63/228,660
Filed on 2021-08-03
Filed on 2021-08-03
Targeting The 5'UTR Of Survival Motor Neuron 2 (SMN2) To Increase Its Expression In A Disease Model Of Spinal Muscular Atrophy (SMA)
US Application 62/796,748
Filed on 2019-01-25
Filed on 2019-01-25
NANOBODIES DIRECTED TO CORONAVIRUS SPIKE PROTEIN RECEPTOR
BINDING DOMAIN AND USES THEREOF
US Application 63/055,865
Filed on 2020-07-23
Filed on 2020-07-23
DUAL-TUNED OPTICALLY CONTROLLED ON-COIL AMPLIFIER FOR HIGH-FIELD MAGNETIC RESONANCE IMAGING SYSTEMS
US Application 63/046,896
Filed on 2020-07-01
Filed on 2020-07-01
HIGH-RESOLUTION CEREBROSPINAL FLUID-SUPPRESSED T2*-WEIGHTED MAGNETIC RESONANCE IMAGING OF CORTICAL LESIONS
US Application 62/838,578
Filed on 2019-04-25
Filed on 2019-04-25
Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis
San Marino
09795720.3
Filed on 2009-12-18
09795720.3
Filed on 2009-12-18
POSITIVE ALLOSTERIC MODULATORS OF DOPAMINE 1 RECEPTOR AND METHOD OF USE THEREOF
US Application 62/639,271
Filed on 2018-03-06
Filed on 2018-03-06